ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companySteinhausenNEURIM PHARMACEUTICALS AG
NEURIM PHARMACEUTICALS AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Neurim Pharmaceuticals is the discovery and development of innovative medications for the treatment of central nervous system (CNS) disorders, with the goal of improving the lives of patients with unmet medical needs.

AI-generated
Presence

Service area

Offering

Products & services

Industry:Pharmaceutical company
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

NEURIM PHARMACEUTICALS AG

✓ Offered4
Drug Development for CNS Disorders
Drug development for CNS disorders, including insomnia in adults, insomnia in children with ASD, NGD and ADHD, plus programs for Alzheimer’s disease, sleep apnea, Parkinson’s disease and autism spectrum disorder.
Marketed Prescription Medicines
Marketed prescription medicines Slenyto and Circadin with prolonged-release melatonin for insomnia in children, adolescents and older adults.
Co-Development and Licensing Partnerships
Partnerships for co-development of early-stage molecules, out-licensing of current and pipeline products, and in-licensing of CNS products for promotion and distribution.
Expanded Access for Investigational Medicines
Case-by-case access to investigational medicines for serious disease when no suitable alternative or trial option exists and regulatory conditions are met.
Trust & reputation

ranQ Trust Score of NEURIM PHARMACEUTICALS AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of November 2026

Without public customer reviews the score stays capped.

NEURIM PHARMACEUTICALS AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
NEURIM PHARMACEUTICALS AG scores 85.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
NEURIM PHARMACEUTICALS AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
NEURIM PHARMACEUTICALS AG scores 77.1 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.77.14%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

NEURIM PHARMACEUTICALS AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once NEURIM PHARMACEUTICALS AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

NEURIM PHARMACEUTICALS AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank NEURIM PHARMACEUTICALS AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of NEURIM PHARMACEUTICALS AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Turmstrasse 18
6312 Steinhausen

At a glance

Legal form
Corporation
UID
CHE-101.076.153
Founded
1999 · 27 years
Last commercial register change
June 21, 2024
Employees
1 to 10

Active in 1 of 26 cantons

  • ZGZug
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
  • Full methodology

    Similar companies

    NG
    Neopharmed Gentili Schweiz GmbH
    Zug
    CT
    Corcept Therapeutics Switzerland GmbH
    Zug
    C(
    Cytokinetics (Switzerland) GmbH
    Zug
    SR
    Scholar Rock Switzerland GmbH
    Zug
    AT
    Aurealis Therapeutics AG
    Zug
    QP
    Quercis Pharma AG
    Zug
    AS
    Alnylam Switzerland GmbH
    Zug
    BM
    Blueprint Medicines (Switzerland) GmbH
    Zug